AUTOLOGOUS CYTOKINE-INDUCED KILLER (CIK) IMMUNOTHERAPY IN A CASE OF DISSEMINATED TUBERCULOSIS

被引：0
|
作者：
Xu, Ping [1 ]
Xu, Jun-Chi [1 ]
Chen, Xin-Nian [1 ]
Ye, Zhi-Jian [1 ]
Wu, Mei-Ying [1 ]
机构：
[1] Fifth Peoples Hosp Suzhou, Suzhou 215000, Jiangsu, Peoples R China
来源：
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES | 2015年 / 32卷 / 01期
关键词：
CIK; disseminated tuberculosi; immunotherapy; PHASE-I; CELLS; LYMPHOMA; TRIAL; VIVO;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
A 23-year-old woman had dry cough, fever and chest tightness for 1 months. Through thoracic CT scan and serological examination, the patient was clinically diagnosed as disseminated tuberculosis. she was given anti-tuberculosis therapy combined with autologous cytokine-induced killer (CIK) immunotherapy. Through the close follow-ups we found that after immunotherapy Her condition would have a swift improvement and she do not appear liver damage after a large doses of antibiotic therapy. In conclusion, adjuvant autologous CIK immunotherapy is an effective approach for disseminated tuberculosis.
引用
收藏
页码：83 / 86
页数：4
相关论文
共 50 条
  • [21] Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study
    Li, Runmei
    Wang, Changli
    Liu, Liang
    Du, Chunjuan
    Cao, Shui
    Yu, Jinpu
    Wang, Shizhen Emily
    Hao, Xishan
    Ren, Xiubao
    Li, Hui
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (11) : 2125 - 2133
  • [22] Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer: A meta-analysis
    Hu, Jianxin
    Hu, Junfeng
    Liu, Xiandong
    Hu, Chao
    Li, Ming
    Han, Wei
    MEDICINE, 2017, 96 (42)
  • [23] Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application
    Meng, Yiming
    Yu, Zhifu
    Wu, Yefeng
    Du, Tianzhao
    Chen, Shi
    Meng, Fanjuan
    Su, Nan
    Ma, Yushu
    Li, Xiaoxi
    Sun, Sulan
    Zhang, Guirong
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (06) : 1379 - 1387
  • [24] Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
    Du, Hansong
    Yang, Jia
    Zhang, Ying
    BMC CANCER, 2020, 20 (01)
  • [25] Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
    Hansong Du
    Jia Yang
    Ying Zhang
    BMC Cancer, 20
  • [26] Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
    Rettinger, E.
    Kuci, S.
    Kuci, Z.
    Weber, G.
    Willasch, A.
    Kreyenberg, H.
    Koehl, U.
    Von Laer, D.
    Fulda, S.
    Klingebiel, T.
    Bader, P.
    KLINISCHE PADIATRIE, 2011, 223 (01): : 52 - 52
  • [27] Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells
    Cappuzzello, Elisa
    Sommaggio, Roberta
    Zanovello, Paola
    Rosato, Antonio
    CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 36 : 99 - 105
  • [28] Genetically modified cytokine-induced killer (CIK) cells for targeted cancer therapy
    Oelsner, Sarah
    Wagner, Juliane
    Friede, Miriam E.
    Pfirrmann, Verena
    Rettinger, Eva
    Schubert, Ralf
    Pfeifer, Heike
    Ullrich, Evelyn
    Bader, Peter
    Wels, Winfried S.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [29] Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo
    Wang, FS
    Liu, MX
    Zhang, B
    Shi, M
    Lei, ZY
    Sun, WB
    Du, QY
    Chen, JM
    WORLD JOURNAL OF GASTROENTEROLOGY, 2002, 8 (03) : 464 - 468
  • [30] Effective activity of cytokine-induced killer (CIK) cells against autologous putative cancer stem cells in solid tumors
    Gammaitoni, L.
    Mesiano, G.
    Giraudo, L.
    Leuci, V.
    Todorovic, M.
    Picciotto, F.
    Carnevale-Schianca, F.
    Grignani, G.
    Aglietta, M.
    Sangiolo, D.
    IMMUNOLOGY, 2012, 137 : 709 - 709
12345